secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0000950170-23-006005
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences raises ~$6M in private placement at $9.00/share
-------------------------------------------------------------------

- Sold 666,334 shares (or pre-funded warrants) at $9.00 each, plus Series A and B investment options for up to 666,334 shares each at $9.00.
- Existing warrants with exercise prices from $37 to $301 amended to $9.00 per share, contingent on closing.
- H.C. Wainwright acted as placement agent with 6% fee and 5% placement agent investment options at $11.25.
- Closing expected March 6, 2023; registration rights agreement requires filing by April 3, 2023.
- Proceeds not explicitly stated but gross from shares alone approximately $6 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023006005/0000950170-23-006005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023006005/rkda-20230302.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-006005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer